e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Sarcoidosis and profiles of other diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum 1,25(OH)2D levels and arterial hypertension (AH) in sarcoidosis patients
A. Rudnicka, E. Puscinska, A. Goljan-Geremek, J. Czerniawska, A. Rozy, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland)
Source:
Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session:
Sarcoidosis and profiles of other diffuse parenchymal lung disease
Session type:
E-Communication Session
Number:
3126
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Rudnicka, E. Puscinska, A. Goljan-Geremek, J. Czerniawska, A. Rozy, J. Chorostowska-Wynimko, D. Górecka (Warsaw, Poland). Serum 1,25(OH)2D levels and arterial hypertension (AH) in sarcoidosis patients. Eur Respir J 2009; 34: Suppl. 53, 3126
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Serum leptin levels in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 259s
Year: 2002
Sildenafil (SIL) reduces serum creatinine (SCr) in patients with pulmonary arterial hypertension (PAH): Relationship to clinical outcomes
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
VEGF serum levels in COPD patients without pulmonary hypertension – a case control study
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions
Source: Eur Respir J 2001; 18: Suppl. 33, 213s
Year: 2001
Serum leptin levels in patients with chronic airway diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005
Serum magnesium levels of patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 107s
Year: 2003
Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency
Source: Eur Respir J 2015; 46: 277-280
Year: 2015
Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Plasma nitrite/nitrate levels: a new biomarker for pulmonary arterial hypertension?
Source: Eur Respir J 2016; 48: 1265-1267
Year: 2016
Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003
Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Serum levels of chitotriosidase in pulmunary sarcoidosis
Source: Annual Congress 2008 - COPD and other environment-related lung diseases
Year: 2008
P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Serum and pulmonary uric acid in pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2000332; 10.1183/13993003.00332-2020
Year: 2021
Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept